Key result
The Contegra valved bovine conduit for pediatric right ventricular outflow tract reconstruction demonstrated a 5-year freedom from explantation of 90% in patients aged 1 to 10 years.
Why the study?
Does the Contegra valved bovine jugular vein graft provide durable outcomes for RVOT reconstruction in pediatric patients?
Population
165 pediatric patients requiring right ventricular outflow tract reconstruction for congenital heart defects.
Design
Cohort
Follow-up
Total 687 patient years
Authors
Loading...
Contegra shows acceptable 7-year durability in pediatric RVOT reconstruction; leaves open whether it outperforms homografts in randomized trials.
Cohort (n=165)
Yes
Does the Contegra valved bovine jugular vein graft provide durable outcomes for RVOT reconstruction in pediatric patients?
The Contegra valved bovine jugular vein graft demonstrates acceptable mid-term performance for pediatric RVOT reconstruction, though event-free survival is significantly lower in infants under 1 year of age.
Breymann et al. (2009) conducted a cohort in Right ventricular outflow tract (RVOT) reconstruction (n=165). Contegra valved bovine conduit was evaluated on Freedom from death, explantation, intervention, stenosis, insufficiency, and degeneration. The Contegra valved bovine conduit for pediatric right ventricular outflow tract reconstruction demonstrated a 5-year freedom from explantation of 90% in patients aged 1 to 10 years.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: